Enregistré dans:
Détails bibliographiques
Auteur principal: Geoffrey C. Wall
Format: Artículo científico
Langue:en
Publié: Centro de investigaciones y Publicaciones Farmacéuticas 2007
Sujets:
Accès en ligne:https://www.redalyc.org/articulo.oa?id=69050408
https://www.redalyc.org/journal/690/69050408/
https://www.redalyc.org/journal/690/69050408/html/
https://www.redalyc.org/journal/690/69050408/69050408.epub
https://www.redalyc.org/journal/690/69050408/movil
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
Table des matières:
  • A pilot study of complementary and alternative medicine use in patients with fibromyalgia syndrome Geoffrey C. Wall Linda L. Krypel Michael J. Miller Derek M. Rees Medicina Fibromyalgia United Stated Complementary Therapies Fibromyalgia syndrome (FMS) is a complexdisorder, with primary symptoms of sleepdisturbances, pain, and fatigue. FMS is one of themost common reasons for patient visits to arheumatologist. Previous studies have suggestedthat complementary and alternative medicine (CAM)use in patients with rheumatic diseases is common,but such data specific to FMS patients is limited.Objective: The following study sought to describethe prevalence of CAM use in a primary carepractice of patients with FMS and assess whetherthese patients discuss CAM use with theirphysician, physician-extender, and/or pharmacist.Methods: A one-group cross-sectional surveydesign was implemented in a large, communitybased,private physician practice of patientsdiagnosed with FMS. A self-administeredquestionnaire was distributed during clinic visits. Itsolicited information related to demographiccharacteristics; FMS-specific health background;whether CAM use had been discussed with a healthcare provider; and the “ever-use” of common typesof CAM. Respondents returned the questionnairevia US mail in a postage-paid, self-addressedenvelope.Results: A total of 115 surveys were distributed with54 returned for analysis (47% completion rate). Thesample was predominantly female, well educatedand had a mean age of 55.6 years. All respondentswere White. Most respondents (92.6%) reportedusing some type of CAM. Exercise (92.2%),chiropractic treatment (48.1%), lifestyle and diet(45.8%), relaxation therapy (44.9%), and dietaryand herbal supplements (36.5%) were mostcommonly reported CAM therapies “ever-used” byrespondents. Dietary and herbal supplements withthe highest prevalence of “ever-use” weremagnesium (19.2%), guaifenesin (11.5%), andmethylsulfonylmethane (MSM) (9.6%).Respondents most commonly discussed CAM withthe clinic rheumatologist and the primary care physician (53.7% and 38.9%, respectively). Only14.8% of respondents discussed CAM with apharmacist. However, a significantly higherproportion of respondents who “ever-used” dietaryand herbal supplements discussed CAM with apharmacist compared to those who never useddietary and herbal supplements [chi square=6.03,p=0.014].Conclusion: This pilot study suggests that CAM useis common in patients diagnosed with FMS.Compared to other healthcare providers,respondents were least likely to discuss CAM with apharmacist. However, respondents who useddietary and herbal supplements were more likely todiscuss CAM with a pharmacist compared to thosewho did not, suggesting the potential influence ofpharmacist intervention. 2007 artículo científico 1885-642X https://www.redalyc.org/articulo.oa?id=69050408 https://www.redalyc.org/journal/690/69050408/ https://www.redalyc.org/journal/690/69050408/html/ https://www.redalyc.org/journal/690/69050408/69050408.epub https://www.redalyc.org/journal/690/69050408/movil en http://www.redalyc.org/revista.oa?id=690 Pharmacy Practice application/pdf Centro de investigaciones y Publicaciones Farmacéuticas Pharmacy Practice (España) Num.4 Vol.5